Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/27/2026

1. NVDA
2. OKTA
3. CRM
4. CRWD
5. VEEV
6. P
7. KKR
8. HPQ
9. NTNX
10. A

Go back to Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.02 -0.19 (2.06%)
Previous Close $9.21    52 Week High $9.23 
Open $9.12    52 Week Low $1.16 
Day High $9.18    P/E N/A 
Day Low $8.97    EPS $-0.30 
Volume 327,500